The Effects of Neurophysiological Facilitation Techniques After Coronary Artery Bypass Graft Surgery

October 11, 2024 updated by: Gamze Aydin, Istanbul University - Cerrahpasa (IUC)

The Effects of Neurophysiological Facilitation Techniques on Cardiopulmonary Parameters After Coronary Artery Bypass Graft Surgery

The aim of the study is to investigate the effects of neurophysiological facilitation techniques, applied in addition to Phase I cardiac rehabilitation in the early postoperative period after coronary artery bypass graft (CABG) surgery, on left ventricular function, respiratory functions, and functional capacity.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

In this prospective randomized controlled study, participants will be randomly divided into two groups: the control group, which will receive Phase I cardiac rehabilitation, and the treatment group, which will receive Phase I cardiac rehabilitation along with the application of neurophysiological facilitation techniques. The participants' left ventricular function, respiratory functions, and functional capacity will be assessed before and after the interventions.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • First-time undergoing open-heart surgery
  • Aged between 50 and 85 years
  • Full cooperation

Exclusion Criteria:

  • Presence of facial, sternum, or rib fractures
  • Chronic renal failure
  • Development of cerebrovascular events
  • Cognitive function impairment
  • Development of deep vein thrombosis in the postoperative period
  • Presence of neuromuscular disease
  • Presence of orthopedic disabilities
  • Intubation duration longer than 24 hours
  • Staying in intensive care for more than 48 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NFT Group
NFT group will receive Phase I cardiac rehabilitation and neurophysiological facilitation techniques.
Other: exercise
exercises with using neurophysiological facilitation techniques and cardiac rehabilitation.
Active Comparator: Control Group
Control group will receive Phase I cardiac rehabilitation alone.
Other: exercise
exercises with using neurophysiological facilitation techniques and cardiac rehabilitation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ecocardiography device
Time Frame: 3 months
ejection fraction will assess with ecocardiography.
3 months
spirometer
Time Frame: 3 months
respiratory function test will assess with spirometer
3 months
6 Minutes walking test
Time Frame: 3 months
functional capacity will assess with 6 minutes walk test.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa (IUC)

Collaborators

Okan University

Investigators

  • Principal Investigator: Gamze Aydın, PhD, Okan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

October 9, 2024

First Submitted That Met QC Criteria

October 11, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 11, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IstanbulOkanUnive

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe